Skip to content
healthcare.dev

Cetirizine Hydrochloride Tablets,10 mg

NDC 49483-692, Cetirizine Hydrochloride, tablet, from TIME CAP LABORATORIES, INC..

Product NDC
49483-692
Status
Listed
Labeler
TIME CAP LABORATORIES, INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA078933
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49483-692 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
49483-692-0149483069201100 TABLET in 1 BOTTLE (49483-692-01)
49483-692-2049483069220200 TABLET in 1 BOTTLE (49483-692-20)
49483-692-5049483069250500 TABLET in 1 BOTTLE (49483-692-50)
49483-692-6549483069265365 TABLET in 1 BOTTLE (49483-692-65)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 49483069250

    GET /v1/drugs/nadac/49483069250

Use it

Look up 49483-692 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49483-692 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49483-692. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.